APA (7th ed.) Citation

PG, R., A, O., A, L., J, B., M, C., P, R., . . . MV, M. (2021). Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(7), 757. https://doi.org/10.1200/JCO.20.02259

Chicago Style (17th ed.) Citation

PG, Richardson, et al. "Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 39, no. 7 (2021): 757. https://doi.org/10.1200/JCO.20.02259.

MLA (9th ed.) Citation

PG, Richardson, et al. "Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 39, no. 7, 2021, p. 757, https://doi.org/10.1200/JCO.20.02259.